Entry |
|
Name |
Metaproterenol;
Orciprenaline
|
Formula |
C11H17NO3
|
Exact mass |
211.1208
|
Mol weight |
211.2576
|
Structure |
|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03A ADRENERGICS, INHALANTS
R03AB Non-selective beta-adrenoreceptor agonists
R03AB03 Orciprenaline
D08300 Orciprenaline (INN)
R03C ADRENERGICS FOR SYSTEMIC USE
R03CB Non-selective beta-adrenoreceptor agonists
R03CB03 Orciprenaline
D08300 Orciprenaline (INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01452 beta2-Adrenergic receptor agonist
DG01044 Orciprenaline
D08300 Orciprenaline
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRB2
D08300 Orciprenaline (INN)
|
Other DBs |
|
KCF data |
ATOM 15
1 C8y C 24.4609 -19.7394
2 C8x C 23.2500 -20.4438
3 C8x C 24.4609 -18.3423
4 C1c C 25.6716 -20.4438
5 C8y C 22.0335 -19.7394
6 C8y C 23.2500 -17.6437
7 C1b C 26.8882 -19.7394
8 O1a O 25.6775 -21.8408
9 C8x C 22.0335 -18.3423
10 O1a O 20.8286 -20.4438
11 O1a O 23.2500 -16.2409
12 N1b N 28.0991 -20.4379
13 C1c C 29.3098 -19.7336
14 C1a C 30.5206 -20.4379
15 C1a C 29.3098 -18.3366
BOND 15
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 2
6 4 7 1
7 4 8 1
8 5 9 2
9 5 10 1
10 6 11 1
11 7 12 1
12 12 13 1
13 13 14 1
14 13 15 1
15 6 9 1
|